Management of the cancer patient with infection and neutropenia

Seminars in Oncology

Volumn 38, Issue 3, 2011, Pages 424-430

  Rapoport, Bernardo Leon ^a,b  

^a Medical Oncology Centre of Rosebank   (South Africa)

^b NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CORTICOSTEROID; HEMOPOIETIC GROWTH FACTOR; PENICILLIN G; RITUXIMAB; VANCOMYCIN;

ANTIBIOTIC THERAPY; B CELL LEUKEMIA; BACTEREMIA; BONE MARROW TRANSPLANTATION; BREAST TUMOR; BRONCHUS TUMOR; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ESOPHAGITIS; ESOPHAGUS CANCER; FEBRILE NEUTROPENIA; HEAD AND NECK TUMOR; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; INFECTION; MORBIDITY; MUCOSAL IMMUNITY; NEUTROPENIA; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RADIATION ESOPHAGITIS; RADIATION PNEUMONIA; SCORING SYSTEM; SPLENECTOMY; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CAUSALITY; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INFECTION; NEOPLASMS; NEUTROPENIA; RISK ASSESSMENT;

EID: 79956226134     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.03.013     Document Type: Conference Paper

References (39)

1. V.A. Morrison Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis Clin Lymphoma Myeloma 9 2009 365 370
2. D.G. Savage, J. Lindenbaum, and T.J. Garrett Biphasic pattern of bacterial infection in multiple myeloma Ann Intern Med 96 1982 47 50 (Pubitemid 12205515)
3. M. Nucci, and E. Anaissie Infections in patients with multiple myeloma Semin Hematol 46 2009 277 288
4. E.H. Kraut Clinical manifestations and infectious complications of hairy-cell leukaemia Best Pract Res Clin Haematol 16 2003 33 40
5. R.I. Fisher, V.T. DeVita Jr, and F. Bostick Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease Ann Intern Med 92 1980 595 599 (Pubitemid 10107546)
6. J.C. Lavoie, J.M. Connors, and G.L. Phillips High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver Blood 106 2005 1473 1478 (Pubitemid 41129618)
7. M. Bower, C. Palmieri, and T. Dhillon AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy Curr Opin Infect Dis 19 2006 14 19 (Pubitemid 43032434)
8. S. Vescia, A.K. Baumgrtner, and V.R. Jacobs Management of venous port systems in oncology: a review of current evidence Ann Oncol 19 2008 9 15
9. G.P. Bodey, M. Buckley, Y.S. Sathe, and E.J. Freireich Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia Ann Intern Med 64 1966 328 340
10. S.L. Gerson, G.H. Talbot, S. Hurwitz, B.L. Strom, E.J. Lusk, and P.A. Cassileth Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann Intern Med 100 1984 345 351 (Pubitemid 14156535)
11. Z. Bhatti, A. Shaukat, N.G. Almyroudis, and B.H. Segal Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients Mycopathologia 162 2006 1 15 (Pubitemid 44025055)
12. M. Lwenberg, C. Stahn, D.W. Hommes, and F. Buttgereit Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands Steroids 73 2008 1025 1029
13. R.S. Cvetkovi, and C.M. Perry Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia Drugs 66 2006 791 820 (Pubitemid 43778729)
14. J. Shortt, and A. Spencer Adjuvant rituximab causes prolonged hypogammaglobulinaemia following autologous stem cell transplant for non-Hodgkin's lymphoma Bone Marrow Transplant 40 2007 597 598
15. C. Cattaneo, P. Spedini, and S. Casari Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments Leuk Lymphoma 47 2006 965 966
16. S. Aksoy, H. Harputluoglu, and S. Kilickap Rituximab-related viral infections in lymphoma patients Leuk Lymphoma 48 2007 1257 1258
17. T. Elter, J.J. Vehreschild, J. Gribben, O.A. Cornely, A. Engert, and M. Hallek Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab Ann Hematol 88 2009 121 132
18. A. Cadili, and C. de Gara Complications of splenectomy Am J Med 121 2008 371 375 (Pubitemid 351626015)
19. R. Parody, R. Martino, and M. Rovira Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation Biol Blood Marrow Transplant 12 2006 734 748 (Pubitemid 43899409)
20. S. Schimpff, W. Satterlee, V.M. Young, and A. Serpick Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia N Engl J Med 284 1971 1061 1065
21. J. Klastersky The changing face of febrile neutropenia-from monotherapy to moulds to mucositis Why empirical therapy? J Antimicrob Chemother 63 2009 14 15
22. M. Paul, S. Borok, A. Fraser, L. Vidal, M. Cohen, and L. Leibovici Additional anti-gram-positive antibiotic treatment for febrile neutropenic cancer patients Cochrane Database Syst Rev 20 2005 CD003914
23. M. Paul, D. Yahav, A. Fraser, and L. Leibovici Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials J Antimicrob Chemother 57 2006 176 189 (Pubitemid 43160156)
24. M. Paul, K. Soares-Weiser, and L. Leibovici Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis BMJ 326 2003 1111 1119
25. M. Paul, K. Soares-Weiser, S. Grozinsky, and L. Leibovici Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia Cochrane Database Syst Rev 3 2003 CD003038
26. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group J Infect Dis 63 1991 951 958
27. P.A. Pizzo, K.J. Robichaud, F.A. Gill, and F.G. Witebsky Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 72 1982 101 111 (Pubitemid 12090793)
28. M.D. Moen, K.A. Lyseng-Williamson, and L.J. Scott Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections Drugs 69 2009 361 392
29. J. Klastersky, M. Paesmans, and E.B. Rubenstein The Multinational Association for Supportive Care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients Clin Oncol 18 2000 3038 3051 (Pubitemid 30644129)
30. A. Uys, B.L. Rapoport, and R. Anderson Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) Risk-Index score Support Care Cancer 12 2004 555 560 (Pubitemid 39062546)
31. J. Klastersky, M. Paesmans, and A. Georgala Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications J Clin Oncol 24 2006 4129 4134 (Pubitemid 46622289)
32. H. Innes, S.L. Lim, A. Hall, S.Y. Chan, N. Bhalla, and E. Marshall Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index: feasibility and safety in routine clinical practice Support Care Cancer 16 2008 485 491 (Pubitemid 351502757)
33. K.V. Rolston, E.B. Rubenstein, and A. Freifeld Early empiric antibiotic therapy for febrile neutropenia patients at low risk Infect Dis Clin North Am 10 1996 223 237 (Pubitemid 26248585)
34. B.L. Rapoport, O. Sussmann, and M.V. Herrera Ceftriaxone plus once daily aminoglycoside with filgrastim for treatment of febrile neutropenia: early hospital discharge vs. standard in-patient care Chemotherapy 45 1999 466 476 (Pubitemid 29531418)
35. W. Renwick, R. Pettengell, and M. Green Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience Biodrugs 23 2009 175 186
36. J. Crawford Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy Pharmacotherapy 23 2003 15S9S
37. M. Pfeundschuh, L. Truemper, and M. Kloess 2-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL Blood 104 2004 634 641 (Pubitemid 38970554)
38. T.J. Smith, J. Khatcheressian, and G.H. Lyman 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 2006 3187 3205 (Pubitemid 46638957)
39. M.S. Aapro, D.A. Cameron, and R. Pettengell European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours Eur J Cancer 42 2006 2433 2453 (Pubitemid 44442936)